The Food and Drug Administration is trying to help mitigate the shortage of EpiPens, those auto-injecting devices used to treat allergic reactions to things like peanuts and bee stings. It’s extended by four months the expiration date for some EpiPen products. The FDA got data from EpiPen maker Mylan that convinced them some of the […]
As we all know, the maker of EpiPen, Mylan, has engaged in price gouging. But this week, the larger health care industry sent a strong message that they are not going to stand for it. On Wednesday, Cigna announced it would only cover the generic version of EpiPen. On Thursday, CVS announced a deal with […]
How will users of the auto-injector pay for the drug they rely on?